ADRA2A polymorphism and smoking in a Turkish population.

The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran.

A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults.

Alpha 2A adrenergic receptor polymorphism is associated with plasma von Willebrand factor levels in a general population.

[Imidazoline receptor]

Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females.

Candidate genes and sensory functions in health and irritable bowel syndrome.

The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.

Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder.

Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type.

Association study between Tourette's syndrome and polymorphisms of noradrenergic genes (ADRA2A, ADRA2C).

An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions.

Associations between an alpha 2A adrenergic receptor gene polymorphism and adolescent personality.

EGF receptor transactivation and PI3-kinase mediate stimulation of ERK by alpha(2A)-adrenoreceptor in intestinal epithelial cells: a role in wound healing.

Do motor control genes contribute to interindividual variability in decreased movement in patients with pain?

Tobacco smoking and the ADRA2A C-1291G polymorphism.

Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.

Human adrenergic alpha 2A receptor C-1291G polymorphism leads to higher consumption of sweet food products.

Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations.

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.